Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

Novo Nordisk announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche announced a ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Creighton rallied from an 11-point deficit in the final minutes of regulation, then outlasted DePaul in two overtimes to earn ...

Tour the campus. Sit in on a class. Talk with professors, coaches, staff, and current students. Located in the heart of Middletown, Connecticut, near tons of great restaurants, hiking trails, and ...